Skip to Content

'
James D. Cox, M.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Hubert L. and Olive Stringer Distinguished Chair in Oncology in Honor of Sue Gribble Stringer, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1965 University of Rochester School of Medicine and Dentistry, Rochester, NY, MD, With Honor, Medicine
1960 Kenyon College, Gambier, OH, AB, Magna Cum Laude, Biology/Chemistry

Postgraduate Training

1963-1964 Clinical Fellowship, Clinical Oncology and Therapeutic Radiology, Penrose Cancer Hospital, Colorado Springs, CO

Experience/Service

Academic Appointments

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1988-1992

Administrative Appointments/Responsibilities

Division Head, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 12/1995-11/2010

Honors and Awards

2011 Gold Medal Gilbert H. Fletcher Society
2011 Honorary Member, Polish Society for Therapeutic Radiation Oncology
2007 Alpha Omega Alpha, University of Rochester School of Medicine
2005 Humanitarian Award, Kenyon College, Gambier, OH
2004-present Councilors, Board of Directors, Radiation Effects Research Foundation
2004 Gold Medal, Texas Radiological Society
2003 Honorary Member, Spanish Association of Radiotherapy and Oncology
2003 The Charles A. LeMaistre, M.D., Outstanding Achievement Award in Cancer, The University of Texas M. D. Anderson Cancer Center
2002 Foreign Member (Corresponding), Royal Academy of Medicine of Belgium
2002 Lecture: Lever Le Voile Sur Le Cancer, Cercle Royal Gaulois, Brussels, Belgium
2001 America's Top Doctors
2000 Honorary Member, European Society for Therapeutic Radiology and Oncology
2000 Janeway Medal and Lecture, American Radium Society
1999 Top Cancer Doctors for Women, Good Housekeeping
1998 Clinical Research Award, Association of Community Cancer Centers, Seattle, WA
1998 Top Doctors, Inside Houston Magazine
1997 Doctor of Science, Kenyon College, Gambier, OH
1997 Gold Medal, American College of Radiology
1997 Gold Medal, Societe Francaise Radiotherapie-Oncologique (SFRO), Paris, France
1997 Medaille Antoine Beclere, Paris, France
1996 Eleventh Annual Simon Kramer Lecture, Thomas Jefferson University, Philadelphia
1994 Dr. Robert D. and Alma W. Moreton Oncology Lecture, Moncrief-M. D. Anderson Cancer Center, Ft. Worth, TX
1994 Gold Medal, del Regato Foundation
1994 Gold Medal, American Society for Therapeutic Radiology and Oncology
1993 Annual Oration in Radiation Oncology, Radiological Society of North America
1992 Gillies Memorial Lecture, University of Iowa
1992 Hubert L. and Olive Stringer Chair in Oncology in Honor of Sue Gribble Stringer, The University of Texas M. D. Anderson Cancer Center
1992 William Caldwell Memorial Lecture, University of Wisconsin
1989 W.G. Cosbie Lecture, Royal College of Physicians and Surgeon of Canada
1988 Honorary Member, Belgian Association for Radiation-Oncology
1987 International Guest Lecturer, 30th Anniversary, Department of Radiology, Hiroshima University Medical School
1986 Sixth Isadore Lampe Lecture, University of Michigan
1985 President, American Society for Therapeutic Radiology and Oncology
1984 Robert Fowler Fellow of the Anti-Cancer Council of Victoria, Australia
1983 Fellow of the American College of Radiology, American College of Radiology
1960 A.B., Magna Cum Laude, Phi Beta Kappa

Selected Publications

Peer-Reviewed Original Research Articles

1. Lopez Guerra JL, Gomez D, Lin S, Levy L, Zhuang Y, Komaki R, Vaporciayan A, Swisher S, Cox JD, Liao Z, Rice D. Risk factors for local and regional recurrence in patients with resected N0-N1 non-smal cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Chest 24(1):67-74, 1/2013. PMID: 23002278.
2. Gomez Dr, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD. Predictors of high-grade esophagitis after definitive three dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapyf or non-small cell ling cancer. Int J Radiat Oncol Biol Phys 84:110-116, 11/2012. PMID: 2292097.
3. Tucker SL, Dong L, Michalski JM, Bosch WR, Winter K, Cox JD, Purdy JA, Mohan R. Do intermediate radiation doses contribute to late rectal toxicity? an analysis of data from Radiation Therapy Oncology Group Protocol 94-06. Int J Radiat Oncol Biol Phys 84(2):390-395, 10/2012. PMID: 22342302.
4. Skinner H,McCurdy MR, Echeverria AE, Lin SH, Welsh JW, O'Reilly MS, Hofstetter WL, Ajani JA, Komaki R, Cox JD, Sandulache VC, Myers JN, Guerrero TM. Metfornim use and improved response to therapy in esophageal adenocarcinoma. Acta Oncol. e-Pub 9/2012. PMID: 22950385.
5. Lopez Guerra JL, Gomez D, Zhuang Y, Levy L, Eapen G, Liu H, Mohan R, Komaki R, Cox J, Liao Z. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83(5):1573-1579, 8/2012. PMID: 22768989.
6. Xiang ZL, Erasmus J, Komaki R, Cox JD, Chang JY. FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy. Radiat Oncol 7:144, 8/2012.
7. Lin SH, Myles B, Wang L, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity score based comparison of long term outcomes with 3D conformal radiotherapy (3DCRT) versus intensity modulated radiation therapy (IMRT) in the treatment of esophageal cancer. Inter J Radiat Oncol Biol Phys. e-Pub 8/2012. PMID: 22867894.
8. Lopez Guerra JL, Gomez DR, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83(4):e537-543, 7/2012. PMID: 22420964.
9. Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti RK, Cox JD. Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. Int J Radiat Oncol Biol Phys 83(3):e363-370, 7/2012. PMID: 22633552.
10. Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 83(3):e345, 7/2012. PMID: 22417808.
11. Tucker SL, Michalski JM, Bosch WR, Mohan R, Dong L, Winter K, Purdy JA, Cox JD. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiother Oncol 104(1):109-113, 6/2012. PMID: 22673726.
12. Koay EJ. Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcome in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. e-Pub 4/2012. PMID: 22543217.
13. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z. Long-term clinical outcome of intensity-modulated radiotherapyfor inoperable non-small-cell lung cancer: The MD Anderson Experience. Int J Radiat Oncol Biol Phys 83(1):332-339, 4/2012. PMID: 22079735.
14. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosi. Int J Radiat Oncol Biol Phys 84(1):e61-67, 4/2012. PMID: 22503522.
15. Amini A, Lin S, Wei C, Allen P, Cox JD, Komaki R. Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the tratment of inoperable non-small cell lung cancer. Radiat Oncol 15(7):33, 3/2012. PMID: 22420631.
16. Cox JD. Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 82(3):1042-1044, 3/2012. PMID: 22284026.
17. Amini A, Yang J, Williamson R, McBurney ML, Erasmus J, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys 82(3):e391-8, 3/2012. PMID: 22284035.
18. Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 83(2):e273-280, 3/2012. PMID: 22440040.
19. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys 82(1):468-474, 1/1/2012. e-Pub 12/1/2010. PMID: 21123005.
20. Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 118(2):444-451, 1/2012. PMID: 21713767.
21. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 81(5):1336-1342, 2012.
22. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 81(5):1336-1342, 12/1/2011. e-Pub 4/4/2011. PMID: 21470796.
23. Komaki R, Wei X, Allen PK, Liao Z, Milas L, Cox JD, O'Reilly M, Chang JY, McAleer MF, Jeter M, Blumenschein GR Jr., Kies MS. Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patietnts with unresectable locally advanced non-small cell lung cancer. Frontier in Oncol 1(52):1-7, 12/2011.
24. Lopez Guerra JL, Wei Q, Yuan X, Gomez D, Liu Z, Zhuang Y, Yin M, Li M, Wang LE, Cox JD, Liao Z. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. Radiother Oncol 101(2):271-7, 11/2011. e-Pub 9/2011. PMID: 21937138.
25. Tucker SL, Thames HD, Michalski JM, Bosch WR, Mohan R, Winter K, Cox JD, Purdy JA, Dong L. Estimation of α/β for Late Rectal Toxicity Based on RTOG 94-06. Int J Radiat Oncol Biol Phys 81(2):600-5, 10/1/2011. e-Pub 3/4/2011. PMCID: PMC3163802.
26. Curran WJ, Paulus R, Langer CJ, Komaki R, Lee J, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410. J Natl Cancer Inst 103(19):1452-1460, 10/2011.
27. Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, Garcia JA, Cox JD. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 81(1):167-74, 9/1/2011. e-Pub 7/17/2010. PMID: 20643518.
28. Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 80(5):1350-1357, 8/1/2011. e-Pub 1/20/2011. PMCID: PMC3117089.
29. Liao Z, Lin SH, Cox JD. Status of particle therapy for lung cancer. Acta Oncol 50(6):745-756, 8/2011. PMID: 21767170.
30. Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for non-small cell lung cancer. Cancer 117(13):3004-3013, 7/1/2011. e-Pub 1/24/2011. PMID: 21264827.
31. Grosshans D, Boehling NS, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang JY. Improving cardiac dosimetry: Alternative beam arrangements for intensity modulated radiation therapy planning in patients with carcinoma of the distal esophagus. PRO 2:41-45, 4/2011.
32. Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. e-Pub 3/2011. PMCID: PMC3174272.
33. Starkschall G, Balter P, Britton K, McAleer MF, Cox JD, Mohan R. Interfractional reproducibility of lung tumor location using various methods of respiratory motion mitigation. Int J Radiat Oncol Biol Phys 79(2):596-601, 2/1/2011. e-Pub 7/16/2010. PMID: 20638189.
34. Valicenti RK, Bae K, Michalski J, Sandler H, Shipley W, Lin A, Cox JD. Does hormone therapy reduce disease recurrence in prostate cancer patients receiving sode-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06. Int J Radiat Oncol Biol Phys 79(5):1323-1329, 1/2011.
35. Liao ZX, Lin Sh, Cox JD. Statistics of particle therapy in lung cancer. Acta Oncol 50:745-756, 2011.
36. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD. Late rectal toxicity on RTOG 94-06: Analysis using a mixture lyman model. Int J Radiat Oncol Biol Phys 78(4):1253-1260, 11/15/2010. e-Pub 7/2/2010. PMCID: PMC2963659.
37. Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, Liu HH, Mohan R, Chen Y, Cox JD, Liao Z. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77(3):691-698, 7/1/2010. e-Pub 10/14/2009. PMID: 19836159.
38. Chang JY, Cox JD. Improving radiation conformality in the treatment of non-small-cell lung cancer. Semin Radiat Oncol 20(3):171-177, 7/2010. PMCID: PMC2905742.
39. Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, Cox JD, Chang JY. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: A virtual clinical study. Int J Radiat Oncol Biol Phys 77(2):357-366, 6/1/2010. e-Pub 8/5/2009. PMCID: PMC2868090.
40. McAleer MF, Moughan J, Byhardt RW, Cox JD, Sause WT, Komaki R. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808. Int J Radiat Oncol Biol Phys 76(3):802-808, 3/2010. e-Pub 6/2009. PMID: 19540055.
41. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402, 2010. e-Pub 8/25/2010. PMCID: PMC2928273.
42. Schechter NR, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA. Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 36(10):1583-91, 10/2009. e-Pub 4/25/2009. PMCID: PMC2758190.
43. Smith A, Gillin M, Bues M, Zhu XR, Suzuki K, Mohan R, Woo S, Lee A, Komaki R, Cox JD. The M. D. Anderson proton therapy system. Med Phys 36(9):4068-4083, 9/2009. PMID: 19810479.
44. McGovern SL, Liao Z, Bucci MK, McAleer MF, Jeter MD, Chang JY, O'Reilly MS, Cox JD, Allen PK, Komaki R. Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? Cancer 115(14):3233-42, 7/15/2009. PMID: 19472405.
45. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-medicare cohort. Int J Radiat Oncol Biol Phys 74(2):482-489, 6/1/2009. e-Pub 3/14/2009. PMID: 19289262.
46. Arjomandy B, Sahoo N, Cox JD, Lee A, Gillin M. Comparison of surface doses from spot scanning and passively scattered proton therapy beams. Phys Med Biol 54:295-302, 06/23/2009, 6/2009. PMID: 19550003.
47. Starkschall G, Britton K, McAleer MF, Jeter MD, Kaus MR, Bzdusek K, Mohan R, Cox JD. Potential dosimetric benefits of four-dimensional radiation treatment planning. Int J Radiat Oncol Biol Phys 73(5):1560-1565, 4/1/2009. e-Pub 2/21/2009. PMID: 19231098.
48. Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, Woo S. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 54(8):2277-2291, 4/21/2009. e-Pub 3/20/2009. PMID: 19305036.
49. Liao Z, Yuan X, Liu Z, Wang LE, Tucker S, Mao L, Wang X, Martel M, Komaki R, Cox JD, Milas L, Qingyi W. Single nucleotide polymorphism at rs1982073:T869C of the TGF-&[beta]1 gene associated with reduced risk of severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiotherapy. J Clin Oncol 10(27):3370-3378, 4/2009.
50. Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1):94-102, 1/1/2009, 1/2009. PMID: 18929448.
51. Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: A phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1):119-127, 1/2009. e-Pub 6/2008. PMID: 18556142.
52. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiation Oncology 4(5):1-7, 1/2009. PMID: 19183471.
53. Xiaomao G, Liao ZX, Komaki R, Wen H, Chang JY, O'Reilly M, Jeter M, Bucci K, Ajani J, Cox JD. Concurrent chemotherapy and proton beam therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 75(3):S289-S290, 2009.
54. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91(3):427-432, 2009. PMID: 18937989.
55. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating quality in clinical cancer research: the M. D. Anderson Cancer Center experience. Oncology 77(2):75-81, 2009. e-Pub 7/1/2009. PMCID: PMC2790774.
56. Chang JY, Komaki R, Bucci MK, Lu C, Wen HY, DeGracia B, Gillin M, Mohan R, Cox JD. Failure patterns and toxicity of concurrent proton therapy and chemotherapy for stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 75(3):S446, 2009.
57. Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher S, Chang JY, Allen PK, Cox JD, Komaki R, Liao Z. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 4(7):880-888, 2009. PMID: 19458557.
58. Albain KS, Swann RS, Rusch VW, Turrisi AT III, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green MR, Miller RC, Ley J, Sause WT, Cox JD. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 374:379-386, 2009. PMID: 19632716.
59. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox JD, Chang JY. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 72(5):1385-1395, 12/2008.
60. Rosen B, Starkschall G, Britton K, Mohan R, Cox JD. Utility of four-dimensional computed tomography for analysis of intrafractional and interfractional variation in lung volumes. Int J Radiat Oncol Biol Phys 72(1):288-294, 9/2008.
61. Hirokawa Y, Yasui W, Komaki-Cox R, Cox JD, Itou K, Tahara E. Radiation therapy for cancer. The fifteenth anniversary of Hiroshima Cancer Seminar Foundation, the Seventeenth International Symposium of Hiroshima Cancer Seminar, November 2007. Cancer Sci 99(6):1287-1291, 6/2008.
62. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71(1):274-280, 5/2008.
63. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy prior to chemoradiation and increased risk of treatment related pneumonitis in esophageal cancer patients treated with definitive chemotherapy. J Thorac Oncol 3(3):277-282, 3/2008.
64. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox JD, Chang JY. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 72(5):1385-1395, 3/2008.
65. Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 70(3):707-714, 3/2008.
66. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non–small cell lung cancer. J Thorac Oncol 3(2):177-186, 2/2008.
67. Kased N, Erasmus JJ, Komaki R, Cox JD. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review. J Thorac Oncol 3(5):534-538, 2008. PMID: 18449010.
68. Ezhil M, Starkschall G, Mohan R, Cox JD, Komaki R. Validation of a model-based segmentation approach to progagating normal aanatomic regions of interest through the 10 phases of respiration. Int J Radiat Oncol Biol Phys 71(3):900-906, 2008.
69. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, Mohan R, Dong L. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 67:906-914, 2007. PMID: 17293240.
70. Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Cox JD, Mohan R, Dong L. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 68:531-540, 2007.
71. Britton RK, Starkschall G, Tucker SL, Pan T, Nelson C, Chang JY, Cox JD, Mohan R, Komaki R. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68:1036-1046, 2007.
72. Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR Jr, Moran C, Allen PK, Komaki R. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys 68:779-785, 2007.
73. Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys 67:620-629, 2007. PMID: 17236979.
74. Zhao K, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, Zhang L, Mohan R, Dong L. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol 84:283-289, 2007.
75. Yom SS, Liao Z, Liu HH, Tucker SL, Ha CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68:94-102, 2007.
76. Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int J Radiat Oncol Biol Phys 69:1409-1416, 2007.
77. Mason KA, Gillin MT, Mohan R, Cox JD. Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. Int J Radiat Oncol Biol Phys 68:968-970, 2007.
78. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68:1349-1358, 2007.
79. Liao Z, Cox JD, Komaki R. Radiochemotherapy of esophageal cancer. J Thorac Oncol 2:553-568, 2007.
80. Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, Balter PA, Cox JD, Komaki R. Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys 68(2):562-571, 2007.
81. Klopp AH, Spaeth E, Dembinski JL, Woodward WA, Munshi A, Meyn RE, Cox JD, Andreeff M, Marini FC. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the microenvironment. Cancer Research 67:11687-11695, 2007.
82. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66:1399-1407, 12/2006.
83. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66:754-61, 11/2006. PMID: 16965865.
84. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66:883-91, 11/2006. PMID: 17011461.
85. Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66(1):108-16, 9/2006. PMID: 16904517.
86. Wang SL, Liao Z, Liu H, Ajani J, Swisher S, Cox JD, Komaki R. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12:5501-8, 9/2006. PMID: 17006988.
87. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66(1):100-7, 9/2006. PMID: 16839700.
88. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65(4):1087-96, 7/2006. PMID: 16682145.
89. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-9, 3/2006. PMID: 16242257.
90. Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 64(3):700-8, 3/2006. PMID: 16242255.
91. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66:883-891, 2006.
92. Wang SL, Liao Z, Liu H, Ajani J, Swisher S, Cox JD, Komaki R. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12:5501-5508, 2006.
93. Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77(3):247-53, 12/2005. PMID: 16298001.
94. Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63(2):362-72, 10/2005. PMID: 16168831.
95. Ha CS, Cabanillas F, Lee MS, Tucker SL, McLaughlin P, Rodriguez MA, Younes A, Romaguera JE, Mesina OM, Cox JD. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. Int J Radiat Oncol Biol Phys 63(1):188-93, 9/2005. PMID: 16111588.
96. de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62(4):965-73, 7/2005. PMID: 15989996.
97. Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 62(3):706-13, 7/2005. PMID: 15936549.
98. Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clin Cancer Res 11(9):3342-8, 5/2005. PMID: 15867233.
99. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Jr, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369-77, 4/2004. PMID: 15050312.
100. Liao Z, Komaki R, Stevens C, Kelly J, Fossella F, Lee JS, Allen P, Cox JD. Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53(3):558-65, 7/2002. PMID: 12062597.
101. Cox JD. Evidence in oncology. The Janeway lecture 2000. Cancer J 6(6):351-7, 11/2000. PMID: 11131481.
102. Michalski JM, Purdy JA, Winter K, Roach M, 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46(2):391-402, 1/2000. PMID: 10661346.
103. Grignon DJ, Caplan R, Sarkar FH, Lawton CA, Hammond EH, Pilepich MV, Forman JD, Mesic J, Fu KK, Abrams RA, Pajak TF, Shipley WU, Cox JD. p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst 89(2):158-65, 1/1997. PMID: 8998185.
104. Cox JD. Evolution and accomplishments of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 33(3):747-54, 10/1995. PMID: 7558966.
105. Pilepich MV, Krall JM, Al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P, Shipley WU, Grignon D, Caplan R, Cox JD. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma - a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45:616-623, 8/1995.
106. Sause WT, Scott CB, Taylor S, Johnson DH, Livingston RB, Komaki R, Emami B, Curran WJ, Turrisi AT, Dar A, Cox JD. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung cancer. J Nat'l Cancer Inst 87:198-205, 5/1995.
107. Cox JD. Brief history of comparative clinical trials in radiation oncology: perspectives from the silver anniversary of the Radiation Therapy Oncology Group. Radiology 192(1):25-32, 7/1994. PMID: 8208947.
108. Jacobs JP, Murray KJ, Schultz CJ, Wilson JF, Goswitz MS, Stevens CW, Cox JD. Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. J Clin Oncol 11(2):233-8, 2/1993. PMID: 8426199.
109. Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim HM, Byhardt RW, Rubin P, Ortiz HG, et al. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313. Cancer 69(11):2744-8, 6/1992. PMID: 1571904.
110. Diener-West M, Pajak TF, Bauer M, Cox JD. Randomized dose-searching phase ILE/II trials of fractionation in radiation therapy for cancer. J Natl Cancer Inst 83(15):1065-71, 8/1991. PMID: 1875413.
111. Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim H, Rubin P, Ortiz H. ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313. Int J Radiat Oncol Biol Phys 20(6):1191-5, 6/1991. PMID: 2045293.
112. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8(9):1543-55, 9/1990. PMID: 2167952.
113. Cox JD. Fractionation: a paradigm for clinical research in radiation oncology. Int J Radiat Oncol Biol Phys 13(9):1271-81, 9/1987. PMID: 3305446.
114. Toohill RJ, Duncavage JA, Grossmam TW, Malin TC, Teplin RW, Wilson JF, Byhardt RW, Haas JS, Cox JD, Anderson T, et al. The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies. Laryngoscope 97(4):407-12, 4/1987. PMID: 3550340.
115. Cox JD, Byhardt RW, Wilson JF, Haas JS, Komaki R, Olson LE. Complications of radiation therapy and factors in their prevention. World J Surg 10(2):171-88, 4/1986. PMID: 3518250.
116. Cox JD. Failure analysis in diagnostic and treatment strategies in cancer management. Cancer Treat Symp 2:1-3, 10/1983.
117. Cox JD, Stanley K, Petrovich Z, Paig C, Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA 245:469-472, 2/1981. PMID: 7452872.
118. Cox JD, Byhardt RW, Komaki R, Greenberg M. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors. Int J Radiat Oncol Biol Phys 6(1):37-40, 1980. PMID: 6245044.
119. Cox JD, Yesner R, Mietlowski W, Petrovich Z. Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung. Cancer 44(1):94-8, 7/1979. PMID: 222435.
120. Cox JD. Central lymphatic irradiation to low dose for advanced nodular lymphoreticular tumors (non-Hodgkin's lymphoma). Radiology 126(3):767-72, 3/1978. PMID: 343169.
121. Cox JD, Koehl RH, Turner WM, King FM. Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 112(1):179-85, 7/1974. PMID: 4208964.
122. Cox JD, Tijerina A. Preliminary results of biopsies following irradiation for locally advanced adenocarcinoma of the prostate. Radiology 112:215-6, 7/1974. PMID: 4832498.

Invited Articles

1. Cox JD. 2011 Gold medal award - tribute to K. Kian Ang. Inter J Radiat Oncol Biol Phys 81(2):A33-A34, 2011.
2. Komaki R, JD Cox. Rationale and initial experiences with proton therapy for cancer of the lung. Proceedings of NIRS-MD Anderson Symposium on Clinical Issues for Particle Therapy:60-61, 3/2008.
3. Goitein M, Cox JD. Should randomized clinical trials be required for proton radiotherapy? J Clin Oncol 26:175-176, 2008.
4. Cox, JD. Current and future status of proton-beam radiation therapy in radiation oncology. Clin Adv Hematol Oncol 5:303-305, 4/2007.
5. Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. J Clin Oncol 25:3-5, 1/2007. PMID: 17194900.
6. Buchholz TA, McBride WH, Cox JD. Preparing for the future of radiation oncology. J Am Coll Radiol 4:560-562, 2007.

Abstracts

1. Komaki R, Allen P, Wei X, Gomez D, Fossella F, Heymach J, Welsh J, O'Reilly MO, Lin S, Cox JD. Thoracic radiotherapy within 6 weeks with concurrent chemotherapy inproved outcome of patients with limited stage small cell lung cancer (LS-SCLC). Int J Radiat Oncol Biol Phys 7(9):S217, 9/2012.
2. McAvoy S, Gomez D, Allen PK, Rineer J, Liao Z, Chang JY, Welsh J, Palmer MB, Cox JD, Komaki R. Efficacy and toxicity of re-irradiation with proton beam therapy for non-small cell lung cancer: An updated institutional experience. Oncology 26(1):7, 4/2012.
3. Cox JD. Proton beam therapy. J Thorac Oncol 4(9):S274, 9/2009.
4. Jeter, MD, Cox JD. Induction chemotherapy improves long-term survival of patients with resectable esophageal cancer receiving chemoradiotherapy followed by surgery. American Society for Therapeutic Radiology and Oncology, Denver, CO, October 16-20, 2005. 6/2005.
5. Smith, A, Wright C, McMaken B, Newhauser W, Styles J, Latinkic M, Hay A, Cox J. A concept for a fully integrated proton therapy facility. Particle Therapy Co-Operative Group 40, Paris, France, June 15-18, 2004. 6/2004.
6. Forster, KM, Stevens CW, Kitamura K, Chang JY, Cox JD, Guerrero TM, Jeter M, Liao Z, Starkschall G, Komaki R. Changes of tumor motion patterns during a course of radiation therapy for lung cancer. . Int J Radiat Oncol Biol Phys 57(2):S234, 6/2003.
7. Chandra, A, Liu, H, Tucker, SL, Liao, ZX, Stevens C, Chang JY, Jeter M, O’Reilly M, Mohan R, Cox JD, Komak R, Guerrero T:. IMRT reduces lung irradiation in distal esophageal cancer 3D CRT. Int J Radiat Oncol Biol Phys 57(2):S384-385, 6/2003.
8. Kirsner, SM, Kudchadker RJ, Prado KL, Ha CS, Lane RG, Wilder RB, Cox JD. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation. American Society for Therapeutic Radiology and Oncology, New Orleans, LA, October 7-9, 2002. 6/2002.
9. Liu, H, Wu Q, Wang X, Mohan R, Stevens G, Liao Z, Komaki R, Cox JD. Feasibility of treating lung cancers using intensity-modulated radiation therapy (IMRT. American Society for Therapeutic Radiology and Oncology, New Orleans, LA, October 7-9, 2002. 6/2002.
10. Chronowsk,i GM, Wilder RB, Ha Cs, Hagemeister FB, Younes A, Rodriguez MA, Fayad L, Hess M, Cabanillas F, Cox JD. Outcomes following salvage therapy for relapsed Hodgkin’s disease in terms of the initial treatment delivered for stage I-II disease. 8th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12-15, 2002, 6/2002.
11. Schlembach, PJ, Wilder RB, Jones D, Ha CS, Fayad LE, Younes A, Hagemeister F, Hess M, Cabanillas F, Cox JD. Results with radiotherapy alone in patients with nonbulky early-stage supradiaphragmatic lymphocyte predominant Hodgkin’s disease. 84th annual meeting of the American Radium Society, Las Croabas, Puerto Rico, April 27 – May 1, 2002, 6/2002.
12. Valicenti, R, Winder K, Cox JD, Sandler H, Michalski J. The effect of toxicity of induction hormonal therapy in prostate cancer patients receiving dose escalated 3D conformal radiation therapy on RTOG 94-06. . American Society for Therapeutic Radiology and Oncology, New Orleans, LA, October 7-9, 2002, 6/2002.
13. Michalski, J, Cox JD. Toxicity Following 3D Radiation Therapy for Prostate Cancer on RTOG 9406 Dose Level IV. American Society for Therapeutic Radiology and Oncology, New Orleans, LA, October 7-9, 2002. 6/2002.

Book Chapters

1. Cox JD. Design and implementation of clinical trials of ion beam therapy. In: Ion Beam Therapy; Fundamental, Technology, Clinical Applications. Ed(s) Ute Linz. Springer: New York, 311-319, 2011.
2. Gomez D, Jeter MD, Komaki R, Cox JD. Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer. In: Advances in Radiationi Oncology in Lung Cancer, 2. Ed(s) Jeremic B. Springer-Verlag: Berlin Heidelberg, 129-141, 2011.
3. Komaki R, Liao Z, Cox JD, Mason KA, Milas L. Radioprotectors and Chemoprotectors in the Management of Lung Cancer. In: Advances in Radiation Oncology in Lung Cancer, 2. Ed(s) Jeremic B. Springer-Verlag: Berlin Heidelberg, 223-245, 2011.
4. Cox JD, Stewat DJ. Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer. In: Lung Cancer Prevention, Management, and Emerging Therapies. Ed(s) Stewart DJ. Humana Press: Spring Street, New York, 161-175, 2010.
5. Dabaja B, Ha C, Cox JD. Leukemias and lymphomas. In: Radiation Oncology Rationale, Technique, Results, 9th. Elsevier, 2009.
6. Hall EJ, Cox JD. Physical and Biologic Basic of Radiation Therapy. In: Radiation Oncology Rationale, Technique, Results, 9th. Elsevier, 3-49, 2009.
7. Milas L, Cox JD. Principles of combining radiation therapy and chemotherapy. In: Radiation Oncology Rstionale, Technique, Results, 9th. Elsevier, 2009.
8. Cox JD. Proton Therapy. In: Radiation Oncology Rationale, Technique, Results, 9th. Elsevier, 2009.
9. Liao Z, Komaki R, Cox JD. The esophagus. In: Radiation Oncology Rationale, Technique, Results, 9th. Elsevier, 2009.
10. Komaki R, Travis L, Cox JD. The lung, pleura, and thymus. In: Radiation Oncology Rationale, Technique, Results, 9th. Elsevier, 2009.
11. Chang JY, Komaki R, Roth JA, Herbst R, Cox JD. Image guidance of screening, staging, and combined modality management of non-small cell lung cancer. In: Image Guided Radiotherapy of Lung Cancer. Ed(s) Cox JD, Chang JY, Komaki R. Informa Healthcare USA, Inc: New York, 1-17, 2008.
12. Chang JY, Mohan R, Cox JD. Image-guided proton radiotherapy in lung cancer. In: Image-Guided Radiotherapy of Lung Cancer. Ed(s) Cox JD, Chang JY, Komaki R. Informa Healthcare USA, Inc. New York, 127-140, 2008.
13. Woodward WA, Cox JD. Molecular Basis of Radiation Therapy. In: The Molecular B asis of Cancer, 3rd. Ed(s) Mendelsohn J, Howley PM, Israel MA, Gray JW, Thompson CB. Saunders Elsevier: Philadelphia, 593-604, 2008. ISBN: 978-1-4160-3703-3.
14. Chang JY, Smith AF, Cox JD. Proton Therapy. In: Lung Cancer, 3rd. Ed(s) Rogh JA, Cox JD, Hong WK. Blackwell Publishing: Malden, 271-282, 2008.
15. Komaki R, Cox JD. Radiation Therapy for Carcinoma of the Lung. In: General Thoracic Surgery. 2, 7. Ed(s) Shields TW, LoCicero K III, Reed CE, Feins RH. Lippincott Williams & Wilkins: Philadelphia, PA, 1457-1468, 2007.
16. Jeter, MD, Komaki R, Cox JD. Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer. In: Medical Radiology – Diagnostic Imaging and Radiation Oncology,. Springer-Verlag: Berlin-Heidelberg, 67-75, 2004.
17. Komaki, R, Chang J, Liao Z, Cox JD, Mason KA, Milas. Radioprotectors and Chemoprotectors in the Management of Lung Cancer. In: Medical Radiology – Diagnostic Imaging and Radiation Oncology. Springer-Verlag: Berlin-Heidelberg, 123-134, 2004.
18. Cox, JD, Ha CS, Wilder RB. Leukemias and Lymphomas. In: Radiation Oncology: Rationale, Technique, Results, 8th. Mosby: St. Louis, 429-443., 2003.
19. Hall, EJ, Cox JD. Physical and biological basis of radiation therapy. In: Radiation Oncology: Rationale, Technique, Results. 8th. Mosby: St. Louis, 1-62, 2003.
20. Milas, L, Cox JD. Principles of combing radiation therapy and chemotherapy. In: Radiation Oncology: Rationale, Technique, Results, 8th. Mosby: St. Louis, 108-124, 2003.
21. Komaki, R, Cox JD:. The Esophagus. In: Radiation Oncology: Rationale, Technique, Results, 8th. Mosby: St. Louis, 429-443, 2003.
22. Komaki, R, Travis EL, Cox JD. The Lung and Thymus. In: Radiation Oncology: Rationale, Technique, Results, 8th. Mosby: St. Louis, 399-426, 2003.
23. Gopal, R, Cox JD, Liao Z, Stevens CW, Starkschall G, Tucker SI, Komaki R:. Effects of amifostine on lung function in patients with non-small-cell lung cancer treated with radiation therapy and chemotherapy. In: Principles and Practice of Radiation Oncology Updates, 3rd: New York, 2-11, 2002.
24. Komaki, R, Cox JD. Radiation Therapy for Carcinoma of the Lung. In: General Thoracic Surgery, 5th. Williams & Wilkins: Media, 1377-1388, 2000.

Books (edited and written)

1. Cox JD, Ang KK. Radiation Oncology Rational, Technique, Results, 9th, 2009.
2. Roth JA, Cox JD, Hong WK. Ed(s) Roth JA, Cox JD, Hong WK. Lung Cancer, 3rd. Blackwell Publishing: Malden, 2008. ISBN: 978-1-4051-5112-2.
3. Cox JD Chang JY, Komaki R. Ed(s) Cox JD, Chang JY, Komaki R. Image-Guided Radiotherapy of Lung Cancer. Imforma Healthcare USA, Inc. New York, 2007.
4. Cox, JD, Ang KK. Radiation Oncology: Rationale, Technique, Results., 8th. Mosby: St. Louis, 2003.
5. del Regato JA, Spjut HJ, Cox JD. Ed(s) del Regato JA, Spjut HJ, Cox JD. Ackerman & del Regato's Cancer: Diagnosis, Treatment and Prognosis, 6th. The CV Mosby Company: St. Louis, 1985.

Last updated: 4/3/2014